首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drug metabolism letters

缩写:

ISSN:1872-3128

e-ISSN:1874-0758

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引426条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sugandha Chaudhari,Shitalkumar Zambad,Mohammed Ali Sugandha Chaudhari
Background: Polypharmacy, that is, two (or more) drugs administered together, may cause chemical or pharmacological interactions. Such interactions may alter the effect of either agent, leading to decrease or increase eff...
Yildiz Yilmaz,Gareth Williams,Markus Walles et al. Yildiz Yilmaz et al.
Background: Although the liver is the primary organ of drug metabolism, the lungs also contain drug-metabolizing enzymes and may, therefore, contribute to the elimination of drugs. In this investigation, the Precision-cut...
Steven X Hu Steven X Hu
Background: Age has a significant impact on activities of hepatic metabolizing enzymes in humans and animals. Flavin-containing Monooxygenase (FMO) and Aldehyde Oxidase (AO) are two important hepatic enzymes. Understandin...
Muthusamy Ramesh,Prasad V Bharatam Muthusamy Ramesh
Background: Diclofenac is a non-steroidal antiinflammatory drug. It is predominantly metabolized by CYP2C9. 4'-hydroxydiclofenac and its quinoneimine are the metabolites of diclofenac. However, few numbers of serious case...
Albert P Li,Kirsten Amaral,Ming-Chih D Ho Albert P Li
Background: We report here an evaluation of a novel experimental system- cofactorsupplemented permeabilized cryopreserved human enterocytes (MetMax™ cryopreserved human enterocytes (MMHE), patent pending) for application...
Poonam Giri,Lakshmikant Gupta,Sneha Naidu et al. Poonam Giri et al.
Background: The use of polypharmacy in the present day clinical therapy has made the identification of clinical drug-drug interaction risk an important aspect of drug development process. Although many drugs can be metabo...
William L Fitch,Cyrus Khojasteh,Ignacio Aliagas et al. William L Fitch et al.
Background: There is a continued need for improvements in the efficiency of metabolite structure elucidation. Objective: We propose to ...
Sandra R Lepri,Daniele Sartori,Simone C Semprebon et al. Sandra R Lepri et al.
Background: Genistein (5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is the most abundant isoflavone in soybean, which has been associated with a lower risk of development of cancer and cardiovascular diseases....
Michael Z Liao,Chunying Gao,Deepak Kumar Bhatt et al. Michael Z Liao et al.
Background: Few studies have systematically investigated pregnancy-induced changes in protein abundance of drug transporters in organs important for drug/xenobiotic disposition. ...